Corgentech to Webcast Presentation From 2006 BIO CEO and Investor Conference
February 08 2006 - 7:00AM
PR Newswire (US)
SOUTH SAN FRANCISCO, Calif., Feb. 8 /PRNewswire-FirstCall/ --
Corgentech Inc. (NASDAQ:CGTK), a biotechnology company, today
announced that John P. McLaughlin, the company's chief executive
officer, will present at the 2006 BIO CEO and Investor Conference
on February 15, 2006 at 11:00 a.m. EST in New York City. Mr.
McLaughlin will discuss the company's pipeline of pain management
and inflammation product candidates and will review the company's
projected milestones for 2006. To access the live webcast or the
subsequent archived recording, log on to http://www.corgentech.com/
and go to the Investors page, and click on Webcasts. Please connect
to Corgentech's website several minutes prior to the start of the
webcast to ensure adequate time for any software download that may
be necessary. About Corgentech Corgentech is a late-stage
biopharmaceutical company focused on the development and
commercialization of novel therapeutic treatments for pain
management and inflammation. Corgentech is based in South San
Francisco, CA. For more information on the company, please visit
http://www.corgentech.com/. DATASOURCE: Corgentech Inc. CONTACT:
Jennifer Cook Williams, Senior Director, Investor Relations of
Corgentech Inc., +1-650-624-9600, or Web site:
http://www.corgentech.com/
Copyright
Corgentech (NASDAQ:CGTK)
Historical Stock Chart
From May 2024 to Jun 2024
Corgentech (NASDAQ:CGTK)
Historical Stock Chart
From Jun 2023 to Jun 2024